Results 211 to 220 of about 546,155 (300)

Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Paratonia is an involuntary and variable resistance to passive movement that emerges with cognitive decline in dementias of different etiologies, with prevalence approaching 90% to 100% in end‐stage disease. It is common in Parkinson disease and the atypical parkinsonisms.
Galit Kleiner   +2 more
wiley   +1 more source

From Uncertainty to Pathogenicity: Resolving a CSF1R Variant of Uncertain Significance Using Long‐Read Transcriptomics

open access: yesMovement Disorders, EarlyView.
Abstract Background CSF1R‐related disorder (CSF1R‐RD) is a severe autosomal dominant leukoencephalopathy characterized by progressive cognitive, neuropsychiatric, and motor decline. Although genetic testing is widely available, numerous likely pathogenic variants in CSF1R frequently remain classified as variants of uncertain significance (VUS ...
Charles Wade   +8 more
wiley   +1 more source

Recent advances in clinical neurophysiology of myoclonus. [PDF]

open access: yesClin Park Relat Disord
Grippe T   +3 more
europepmc   +1 more source

Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset

open access: yesMovement Disorders, EarlyView.
Abstract Background Longitudinal studies of seed‐based functional connectivity (SBFC) in young adult Huntington's disease gene‐expanded (HDGE) individuals are rare, and none, to our knowledge, have examined adult cohorts decades from predicted clinical motor diagnosis.
Michela Leocadi   +13 more
wiley   +1 more source

Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine. [PDF]

open access: yesClin Neurophysiol Pract
Plensäll T   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy